PHOSPHORAMIDATE DERIVATIVES OF CHRYSIN
277
(d, J = 6.2, C-1ꢁꢁ), 132.15 (C-3ꢁ, 5ꢁ), 130.87 (C-1ꢁ), 129.83 (C-3ꢁꢁ, 5ꢁꢁ), 129.14 (C-4ꢁ),
126.40 (C-2ꢁ, 6ꢁ), 125.39 (C-4ꢁꢁ), 120.18, 120.13 (d, J = 4.7, C-2ꢁꢁ, 6ꢁꢁ), 108.34 (C-10),
106.03 (C-3), 104.05, 104.00 (d, J = 3.7, C-6), 99.37, 99.28 (d, J = 4.6, C-8). 61.79,
61.77 (OCH2), 50.49 (CH-NH), 21.00 (CH3), 14.07 (OCH2CH3). 31P NMR (CDCl3) δ:
−2.98, −3.00. IR(KBr) νmax(cm−1): 1257 (P O), 3200 (NH). ESI MS m/z: 532 [M +
Na]+. A molecular formula of C26H24NO8P was determined from the molecular ion peak
at 510.1318 m/z [M + H]+ (calc. 510.1318 for C26H24NO8PH) obtained by HR MS.
1
Compound 4b (C28H28NO8P). Yield (59%); mp 149–150◦C. H NMR (400.13
MHz, CDCl3) δ: 12.77 (s, 1H, 5-H), 7.83 (d, 2H, J = 7.4, 2ꢁ, 6ꢁ-H), 7.52–7.45 (m, 3H, C-3ꢁ,
4ꢁ, 5ꢁ), 7.37–7.27 (m, 4H, H-2ꢁꢁ, 3ꢁꢁ, 5ꢁꢁ, 6ꢁꢁ), 7.20–7.16 (m, 1H, H-4ꢁꢁ), 7.05 (s, 1H, 8-H),
6.70 (s, 1H, 3-H), 6.67, 6.62 (d, 1H, J = 2.0, 6-H), 4.38–4.33 (m, 1H, NH), 4.14–4.08
(m, 1H, NH CH), 3.68, 3.65 (s, 3H, OCH3), 1.73–1.65 (m, 1H, CH-(CH3)2), 1.65–1.52
(m, 2H, CH2 CH (CH3)2), 0.90, 0.88 (d, 6H, J = 3.7, CH-(CH3)2). 13C NMR (100.61
MHz, CDCl3) δ: 182.69, 182.69 (C-4), 173.75, 173.69 (d, J = 4.0, C O), 164.56, 164.54
(C-2), 162.05, 162.02 (C-5), 156.93 (C-9), 156.09, 156.04 (d, J = 3.7, C-7), 150.49, 150.43
(C-1ꢁꢁ), 132.12 (C-3ꢁ, 5ꢁ), 130.73 (C-1ꢁ), 129.75, 129.80 (C-3ꢁꢁ, 5ꢁꢁ), 129.09 (C-4ꢁ), 126.32
(C-2ꢁ, 6ꢁ), 125.30 (C-4ꢁꢁ), 120.18, 120.09 (d, J = 5.0, C-2ꢁꢁ, 6ꢁꢁ), 108.21 (C-10), 105.90
(C-3), 104.02, 103.95 (C-6), 99.34, 99.27 (d, J = 4.5, C-8), 53.38, 53.35 (NH-CH), 52.33,
52.28 (OCH3), 43.57, 43.51 (d, J = 1.3, CH2-CH-(CH3)2), 24.35, 24.28 (CH-(CH3)2),
22.68, 21.75 (CH (CH3)2). 31P NMR (CDCl3) δ: −2.23, −2.41. IR(KBr) νmax(cm−1):
1253(P O), 3184(NH). ESI MS: m/z: 538[M + H]+, 1097[2M + Na]+. A molecular
formula of C28H28NO8P was determined from the molecular ion peak at 538.1639 m/z [M
+ H]+ (calc.538.1631 for C28H28NO8PH) obtained by HR MS.
1
Compound 4c (C29H30NO8P). Yield (54%); mp 129–130◦C. H NMR (400.13
MHz, CDCl3) δ: 12.71, 12.71 (s, 1H, 5-H), 7.83 (d, 2H, J = 7.0, 2ꢁ, 6ꢁ-H), 7.52–7.45 (m, 3H,
C-3ꢁ, 4ꢁ, 5ꢁ), 7.36–7.27 (m, 4H, 3ꢁꢁ, 2ꢁꢁ, 5ꢁꢁ, 6ꢁꢁ-H), 7.20–7.18 (m, 1H, 4ꢁꢁ-H), 7.05 (d, 1H, J =
1.36, 8-H), 6.70 (s, 1H, 3-H), 6.67, 6.63 (d, 1H, J = 1.68, 6-H), 4.30 (d, 1H, J = 3.7, NH),
4.15–4.08 (m, 3H, NH CH, OCH2), 1.59–1.53 (m, 2H, CH2 CH (CH3)2), 1.26–1.19
(m, 3H, OCH2CH3), 0.91, 0.89 (d, 6H, J = 4.0, CH-(CH3)2). 13C NMR (100.61 MHz,
CDCl3) δ: 182.7 (C-4), 173.3, 173.2 (d, J = 4.1, C O), 164.5 (C-2), 162.1, 162.0 (C-5),
156.9(C-9), 156.1 (d, J = 6, C-7), 150.5 (d, J = 1.7, C-1ꢁꢁ), 132.1 (C-3ꢁ, 5ꢁ), 130.8 (C-1ꢁ),
129.8, 129.7 (C-3ꢁꢁ, 5ꢁꢁ), 129.1 (C-4ꢁ), 126.3 (C-2ꢁ, 6ꢁ), 125.3 (C-4ꢁꢁ), 120.2, 120.1 (d, J =
5.0, C-2ꢁꢁ, 6ꢁꢁ), 108.2 (C-10), 105.9 (C-3), 104.1, 103.1 (d, J = 3.4, C-6), 99.4, 99.3 (d, J =
4.5, C-8), 61.4, 61.5 (OCH2), 53.5, 53.4 (NH CH), 43.7, 43.6 (CH2 CH (CH3)2), 24.4,
24.3 (CH (CH3)2), 22.7, 21.8 (C CH (CH3)2). 31P NMR (CDCl3) δ: −2.16, −2.34.
IR(KBr) νmax(cm−1): 1252 (P O), 3188 (NH). ESI MS m/z: 574 [M + Na]+, 1125 [2M +
Na]+. A molecular formula of C28H28NO8P was determined from the molecular ion peak
at 552.1782 m/z [M + H]+ (calc. 552.1787 for C29H30NO8PH) obtained by HR MS.
1
Compound 4d (C24H20NO8P). Yield (58%); mp 156–157◦C. H NMR (400.13
MHz, CDCl3) δ: 12.75 (s, 1H, 5-H), 7.88–7.86 (m, 2H, 2ꢁ, 6ꢁ-H), 7.56–7.50 (m, 3H, C-3ꢁ,
4ꢁ, 5ꢁ), 7.39–7.26 (m, 4H, H-2ꢁꢁ, 3ꢁꢁ, 5ꢁꢁ, 6ꢁꢁ), 7.23–7.19 (m, 1H, H-4ꢁꢁ), 7.06, 7.06 (d d, 1H,
J = 2.1, J = 1.0, 8-H), 6.71 (s, 1H, 3-H), 6.66, 6.65 (d d, 1H, J = 2.0, J = 0.6, 6-H),
3.92 (d, 2H, J = 9.8, CH2-NH), 3.75 (s, 3H, OCH3). 13C NMR (100.61 MHz, CDCl3) δ:
182.76 (C-4), 170.40 (d, J = 9.0, C O), 164.71 (C-2), 162.17 (C-5), 157.05 (C-9), 155.83
(d, J = 6.3, C-7), 150.28 (d, J = 7.0, C-1ꢁꢁ), 132.19 (C-3ꢁ, 5ꢁ), 130.84 (C-1ꢁ), 129.91 (C-2ꢁꢁ,
6ꢁꢁ), 129.16 (C-4ꢁ), 126.42 (C-2ꢁ, 6ꢁ), 125.51 (C-4ꢁꢁ), 120.14 (d, J = 4.7, C-3ꢁꢁ, 5ꢁꢁ), 108.43
(C-10), 106.04 (C-3), 104.01 (d, J = 6.4, C-6), 99.36 (d, J = 4.6, C-8). 52.65 (OCH3), 42.98